Evidence map›Paper›PMID 25769718›Full record

ReviewSurgical oncology clinics of North America2015

Long-term follow-up for melanoma patients: is there any evidence of a benefit?

Natasha M Rueth, Kate D Cromwell, Janice N Cormier

Abstract readReview
In one paragraph

Review in Surgical oncology clinics of North America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Primary Cutaneous Melanoma-Management in 2024.Journal of clinical medicine · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Imaging of pediatric cutaneous melanoma.Pediatric radiology · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natasha M RuethDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, 1400 Holcombe Boulevard, Houston, TX 77230-1402, USA.
Kate D CromwellDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, 1400 Holcombe Boulevard, Houston, TX 77230-1402, USA.
Janice N CormierDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, 1400 Holcombe Boulevard, Houston, TX 77230-1402, USA. Electronic address: jcormier@mdanderson.org.

Funding

Effective surveillance strategies for melanoma patientsR01CA127328 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CORMIER, JANICE N · 2008 to 2010
$972k
NCI NIH HHS R01 CA127328
6 · The paper itself

Abstract

As the incidence of melanoma and the number of melanoma survivors continues to rise, optimal surveillance strategies are needed that balance the risks and benefits of screening in the context of contemporary resource use. Detection of recurrences has important implications for clinical management. Most current surveillance recommendations for melanoma survivors are based on low-level evidence with wide variations in practice patterns and an unknown clinical impact for the melanoma survivor.

Indexed as

Early Detection of CancerHumansMelanomaNeoplasm Recurrence, LocalSkin NeoplasmsSurvivorsCost-effectivenessDiagnostic imagingEvidence-based surveillanceGuidelinesMelanomaSurvivorship

Identifiers

PMID25769718
PMCPMC4359716

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.